Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?

被引：7

作者：

Anastasilakis, Athanasios D. ^{[1
]}

Tournis, Symeon ^{[2
]}

Yavropoulou, Maria P. ^{[3
]}

Polyzos, Stergios A. ^{[4
]}

Makras, Polyzois ^{[5
]}

机构：

[1] 424 Gen Mil Hosp, Dept Endocrinol, Thessaloniki, Greece

[2] Univ Athens, KAT Hosp, Sch Med, Lab Res Musculoskeletal Syst Th Garofalidis, Kifisia, Greece

[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Lab Clin & Mol Endocrinol, Thessaloniki, Greece

[4] Aristotle Univ Thessaloniki, Sch Med, Dept Pharmacol 1, Thessaloniki, Greece

[5] 251 Hellen Air Force & VA Gen Hosp, Dept Endocrinol & Diabet, Athens, Greece

来源：

CALCIFIED TISSUE INTERNATIONAL | 2018年 / 103卷 / 01期

关键词：

BISPHOSPHONATE THERAPY; OSTEOPOROSIS;

D O I：

10.1007/s00223-018-0409-1

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：107 / 108

页数：2

共 11 条

[1]

Multiple clinical vertebral fractures following denosumab discontinuation [J].

Anastasilakis, A. D. ;

Makras, P. .

OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1929-1930

[2]

Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases [J].

Anastasilakis, Athanasios D. ;

Polyzos, Stergios A. ;

Makras, Polyzois ;

Aubry-Rozier, Berengere ;

Kaouri, Stella ;

Lamy, Olivier .

JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) :1291-1296

[3]

Loss of treatment benefit due to low compliance with bisphosphonate therapy [J].

Beest, F. J. A. Penning-van ;

Erkens, J. A. ;

Olson, M. ;

Herings, R. M. C. .

OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) :511-517

[4]

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension [J].

Bone, Henry G. ;

Wagman, Rachel B. ;

Brandi, Maria L. ;

Brown, Jacques P. ;

Chapurlat, Roland ;

Cummings, Steven R. ;

Czerwinski, Edward ;

Fahrleitner-Pammer, Astrid ;

Kendler, David L. ;

Lippuner, Kurt ;

Reginster, Jean-Yves ;

Roux, Christian ;

Malouf, Jorge ;

Bradley, Michelle N. ;

Daizadeh, Nadia S. ;

Wang, Andrea ;

Dakin, Paula ;

Pannacciulli, Nicola ;

Dempster, David W. ;

Papapoulos, Socrates .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07) :513-523

[5]

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension [J].

Cummings, Steven R. ;

Ferrari, Serge ;

Eastell, Richard ;

Gilchrist, Nigel ;

Jensen, Jens-Erik Beck ;

McClung, Michael ;

Roux, Christian ;

Torring, Ove ;

Valter, Ivo ;

Wang, Andrea T. ;

Brown, Jacques P. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (02) :190-198

[6]

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis - A randomized, double-blind, placebo-controlled trial [J].

Greenspan, SL ;

Emkey, RD ;

Bone, HG ;

Weiss, SR ;

Bell, NH ;

Downs, RW ;

McKeever, C ;

Miller, SS ;

Davidson, M ;

Bolognese, MA ;

Mulloy, AL ;

Heyden, N ;

Wu, M ;

Kaur, A ;

Lombardi, A .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) :875-883

[7]

Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward [J].

Khosla, Sundeep ;

Cauley, Jane A. ;

Compston, Juliet ;

Kiel, Douglas P. ;

Rosen, Clifford ;

Saag, Kenneth G. ;

Shane, Elizabeth .

JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (03) :424-430

[8]

The importance of bisphosphonate therapy mass in men after therapy with teriparatide [human parathyroid hormone(1-34)] [J].

Kurland, ES ;

Heller, SL ;

Diamond, B ;

McMahon, DJ ;

Cosman, F ;

Bilezikian, JP .

OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :992-997

[9]

Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates [J].

Tripto-Shkolnik, Liana ;

Rouach, Vanessa ;

Marcus, Yonit ;

Rotman-Pikielny, Pnina ;

Benbassat, Carlos ;

Vered, Iris .

CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) :44-49

[10]

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS [J].

Tsourdi, Elena ;

Langdahl, Bente ;

Cohen-Solal, Martine ;

Aubry-Rozier, Berengere ;

Eriksen, Erik Fink ;

Guanabens, Nuria ;

Obermayer-Pietsch, Barbara ;

Ralston, Stuart H. ;

Eastell, Richard ;

Zillikens, M. Carola .

BONE, 2017, 105 :11-17

← 1 2 →